It is commonly accepted that radiotherapy is a first choice for treatment of T1 glottic cancer. However, side effects caused by irradiation are sometimes troublesome to a patient and to a physician. Among side effects, oncogenic problem and late radiation change are most undesirable and may become fatal. Hence, we avoid radiation therapy especially for younger aged patients.
It was Strong and Jako who first reported the use of laser in the larynx in 1972.
The CO2 laser equipment connected to an operating microscope has its beam focused just on the operating field. It is reflected through a movable mirror, being easily handled and guided in all direction on the visually magnified operating field. It is a cutting tool of high precision. A NiiC CO2 laser unit, model-60Z connected to a Zeiss operating microscope has been employed in continuous mode with power varying from 8 to 20 watts. All patients were submitted to conventional general anesthesia with endotracheal tube covered by aluminum foil, to avoid endotracheal explosion. The tracheal lumen just below the sub glottic space is also filled by small wet cotton ball, in order to protect the cuff and the mucosa. After vaporization, the burned tissue is carefully removed by a wet small cotton ball to certify the complete destruction of the lesion. Further biopsy specimens are obtained from the margins. Especially in cases of anterior comissure involvement, Laser Surgery for T1 Glottic Carcinoma From those 40 patients, 27 were treated with laser alone, with definitive cure inten tion. Among them, 6 underwent laser treatment after radiation failure. The other 13 patients were submitted to laser vaporization plus radiation therapy, although one of them was laryngectomized few days later, because it was a T1b case after radiation failure ( Table 1 ). The reasons that determined the adjuvant therapy were anterior comissure involvement in 5 cases, large tumor in 4 cases, entire vocal fold involvement in 3 cases and tumor extending to whole bilateral vocal folds in 1 case (Table 2 ).
Results
Among those 27 patients that received only laser therapy as definitive treatment, 19 were T1a lesion and the other 8 were T1b. Anterior comissure was involved in 9 cases (8 T1b and 1 T1a); vocal process was involved in 2 cases (both T1a); anterior comissure and vocal process were involved in 1 T1a case, and the other 15 cases were lesions that compromised only the free edge of vocal fold ( Table 3 ). The mean follow up was 19.2 months.
Recurrence was observed in 2 cases, of which one was T1b (without vocal process involvement) and the other was T1a with anterior comissure and vocal process involve ment after radiation failure.
From those 12 patients that received laser therapy and adjuvant therapy, 6 were T1a and 6 T1b lesion. Anterior comissure was involved in 6 cases (1 T1a and 5 T1b); vocal process was involved in 1 T1a case; both anterior comissure and vocal process were involved in 3 cases (2 T1a and 1 T1b) and the other 2 cases were T1a lesion with Now, more than 15 years after the introduction of laser in laryngeal surgery, the results of its use are not so good as expected. In our experience, anterior comissure involvement seems to be associated to worse results, as well as those cases with extension to the vocal process. In our opinion, those cases of worse results are due to the difficulty in total vaporization of the tumor or incomplete determination of the exten sion of the lesion. It is not easy, for example, to be sure that the cartilage at the anterior comissure is not involved even biopsy is made just following the laser vaporization.
We are aware that in the beginning of our experience we used laser alone to some more extensive T1 lesions, as those crossing the anterior comissure or extending to the vocal process. But more recently we have tried to associate another therapy, as radiation, in such a case. In this association, however, it is impossible to determine which one plays the main role. 
